Novavax Correlations

NVAX Stock  USD 8.69  0.32  3.55%   
The current 90-days correlation between Novavax and Moderna is 0.68 (i.e., Poor diversification). The correlation of Novavax is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Novavax Correlation With Market

Average diversification

The correlation between Novavax and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Novavax and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

Moving together with Novavax Stock

  0.64PFE Pfizer Inc Earnings Call This WeekPairCorr
  0.69ACHC Acadia HealthcarePairCorr

Moving against Novavax Stock

  0.48LFCR Lifecore BiomedicalPairCorr
  0.41SEM Select Medical HoldingsPairCorr
  0.32MD Mednax IncPairCorr
  0.45688217 Shanghai RightongenePairCorr
  0.44906548CR1 US906548CR12PairCorr
  0.32BRK-B Berkshire HathawayPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
INOMRNA
AZNMRNA
AZNVXRT
AZNBNTX
VXRTMRNA
AZNINO
  
High negative correlations   
BNTXINO
VXRTINO

Risk-Adjusted Indicators

There is a big difference between Novavax Stock performing well and Novavax Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Novavax's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Novavax Corporate Management

Mark CaseyChief VPProfile
JD EsqSenior OfficerProfile
Robert MDSenior OfficerProfile
Ian WatkinsExecutive OfficerProfile